For WAPPS-Hemo users located in Europe, McMaster is excited to announce the launch of McMaster PopPK. If you see value in using a CE-marked platform, then McMaster PopPK is now available for you. This new CE-marked platform provides individual pharmacokinetic parameters based on the trusted WAPPS-Hemo engine. McMaster PopPK is CE-marked as an in vitro diagnostic device class I in accordance with the EU IVD Directive. McMaster PopPK supports myWAPPS and florioTM to display estimated factor levels via patient smartphone apps.
WAPPS-Hemo users can request to migrate their center to McMaster PopPK, and move all their patients at that time. You also have the option to migrate individual patients only by selecting the McMaster PopPK icon. This icon will appear on the patient record in the WAPPS-Hemo dashboard after their center has been created in McMaster PopPK. The WAPPS-Hemo user names and passwords will not change; and no additional registration is required for patients. The patient records in McMaster PopPK will remain visible in WAPPS-Hemo for ease of reference. Additional information can be found in the McMaster PopPK user manual, which can be requested here.
There will be no change in the availability of WAPPS-Hemo worldwide, including in Europe.
McMaster PopPK has been developed with the support of Sobi. Florio GmbH, the manufacturer of florioTM is a wholly owned subsidiary of Sobi.
